The DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity
Open accessAbstract
OBJECTIVE: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. SUBJECTS: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). RESULTS: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. CONCLUSION: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Demographics ranging between men, women, and postmenopausal women show that there is a correlation between a beneficial phenotype for metabolic outcomes and subcutaneous fat accumulation, whereas visceral fat accumulation, including omental adipocyte hypertrophy, leads to a decline in metabolic health (20–25).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“However, larger adipocytes are positively correlated with adipose tissue macrophage number and production of pro-inflammatory cytokines TNF-a and IL-6 in mice[42].”
BackgroundAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“‘two hit’ hypothesis for steatohepatitis[46].”
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Large adipocytes are more likely to produce pro-inflammatory adipokines[12] and to demonstrate increased basal and catecholamine-stimulated lipolysis[24].”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · cited 4×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundInfluentialWeyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Gender differences in fat metabolism
Blaak, E. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200111000-00006 · Cited by 709 · cited 1×
“women than in men, whereas free fatty acid release from the upper body depots is comparable[38].”
Background
Cited by
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I., & Kim, J. B. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00030 · Cited by 1,206
“A frequent feature of the MHO population is a lower number of immune cells and a higher proportion of relatively small adipocytes in adipose tissues (77, 114, 115, 117).”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“Cross-sectional studies have demonstrated that the size of visceral adipocytes is negatively correlated with insulin sensitivity (O’Connell et al., 2010; Hardy et al., 2011), and these findings allow proposing adipocyte size as an IR determinant (O’Connell et al.”
BackgroundSamson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Metadata
- Authors
- O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D.
- Affiliations
- St. Vincent's University Hospital (IE)
- Christchurch Hospital (NZ)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-01
- Volume
- 5
- Issue
- 4
- Pages
- e9997
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2848665
- OpenAlex
- W2115664664
- Cited by
- 211
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 4 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 9
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Medical Research Charities Group
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- metabolically healthy obesity, omental adipocytes, subcutaneous adipocytes, adipocyte size, morbid obesity, insulin resistance, hepatic steatosis, liver fibrosis, steatohepatitis, bariatric surgery, metabolic syndrome, HOMA-IR
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Omentum, Body Mass Index, Adipocytes, Metabolic Syndrome, Cell Size, Subcutaneous Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity. https://app.cochat.ai/papers/10.1371/journal.pone.0009997
- The paper
- O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D. (2010). The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity. PLoS ONE. https://doi.org/10.1371/journal.pone.0009997
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.